S&P 500
(0.03%) 5 088.80 points
Dow J
(0.16%) 39 132 points
Nasdaq
(-0.28%) 15 997 points
Oil
(-0.03%) $76.47
Gas
(11.17%) $1.782
Gold
(-0.28%) $2 043.70
Silver
(0.52%) $23.10
Platinum
(-0.42%) $905.80
USD/EUR
(0.06%) $0.924
USD/NOK
(0.36%) $10.54
USD/GBP
(-0.12%) $0.789
USD/RUB
(1.83%) $94.73

Realtime updates for Herantis Pharma Oyj [HRTIS.HE]

Exchange: HEL Sector: Healthcare Industry: Biotechnology
Last Updated23 Feb 2024 @ 10:36

1.45% 1.400

Live Chart Being Loaded With Signals

Commentary (23 Feb 2024 @ 10:36):

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD...

Stats
Today's Volume 3 796.00
Average Volume 9 027.00
Market Cap 28.22M
EPS €0 ( 2023-08-24 )
Next earnings date ( €0 ) 2024-03-05
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E 1.400
ATR14 €0 (0.00%)

Herantis Pharma Oyj Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Herantis Pharma Oyj Financials

Annual 2022
Revenue: €0
Gross Profit: €0 (0.00 %)
EPS: €-0.730
Q4 2016
Revenue: €0.00
Gross Profit: €0.00 (0.00 %)
EPS: €-0.440
Q4 2015
Revenue: €800.00
Gross Profit: €0.00 (0.00 %)
EPS: €-0.600
Q2 2014
Revenue: €0.00
Gross Profit: €0.00 (0.00 %)
EPS: €-0.739

Herantis Pharma Oyj

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD. The company was incorporated in 2008 and is based in Espoo, Finland.

AboutLive Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators